Citi opens ‘positive catalyst watch’ on Establishment Labs

Citi analyst Joanne Wuensch opened a “90-day positive catalyst watch” on Establishment Labs while keeping a Buy rating on the shares with a $79 price target. The company is approaching regulatory approval for Motiva in China and potentially the U.S. by the end of 2023, the analyst tells investors in a research note. The firm says management expects to begin commercialization in China this year, sizing the opportunity at 100,000 breast augmentation procedures annually.